 Home > Active Ingredient News > Study of Nervous System > JNNP: Erinumab is effective in treating migraine

JNNP: Erinumab is effective in treating migraine

 Last Update: 2021-12-26
 Source: Internet
 Author: User

Tags

et 30

knd number 4

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Migraine is a common, highly disabling, occasional or chronic neurovascular headache disease.

Erinumab (Erenumab) is an effective monoclonal antibody that targets and blocks typical CGRP receptors

LIBERTY (NCT03096834) is a multi-center, randomized, double-blind, placebo-controlled, parallel group

Patient arrangements in the study

Overall, 181/240 (75.

Patient's treatment effect

During the 2-year follow-up period, Erinumab was safe and well tolerated

In short, Erinumab is a novel, effective and safe preventive treatment option for migraine

FerrariMD ,ReuterU ,GoadsbyPJ FerrariMDFerrari ReuterUReuter GoadsbyPJGoadsby, et alTwo-year efficacy and safety of erenumab in participants with episodic migraine and 2–4 prior preventive treatment failures: results from the LIBERTY studyJournal of Neurology , Neurosurgery & PsychiatryPublished Online First: 29 NovemberPublished Online First:2021.
doi: 10.
1136/jnnp-2021-327480doi:

Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Sodium bromide airuike

CAS No.: 7647-15-6

Industrial Grade

$10/KG EXW

Brivaracetam357336-20-0

CAS No.: 357336-20-0

API Grade

$100/KG EXW

Quetiapine fumarate CAS 111974-72-2

CAS No.: 111974-72-2

Pharmaceutical Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.